Daniel L Cheney

Title: The Innovative Contributions of Daniel L Cheney

Introduction

Daniel L Cheney is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit useful pharmacological activity. With a total of 3 patents, Cheney's work has had a meaningful impact on medical treatments.

Latest Patents

Cheney's latest patents focus on substituted compounds, specifically those involving sulfinic acid, sulfonic acid, and sulfonylamino. These compounds are designed to inhibit the activity of Factor Xa, which plays a crucial role in blood coagulation. The inventions are directed towards pharmaceutical compositions that can be used to treat patients suffering from various medical disorders. The compounds of formula I, as described in his patents, are particularly aimed at ameliorating physiological conditions that can benefit from the administration of Factor Xa inhibitors.

Career Highlights

Daniel L Cheney is associated with Rhone-Poulenc Rorer Pharmaceuticals Inc., where he has been instrumental in advancing pharmaceutical research and development. His innovative work has contributed to the creation of effective treatments that address critical health issues.

Collaborations

Cheney has collaborated with notable colleagues, including William R Ewing and Michael R Becker. These partnerships have fostered a collaborative environment that enhances the innovation process within the pharmaceutical industry.

Conclusion

Daniel L Cheney's contributions to pharmaceutical inventions highlight the importance of innovation in medical treatments. His work on Factor Xa inhibitors showcases the potential of scientific research to improve patient care and health outcomes.